Ofloxacin + TinidazoleThird Party Manufacturing in India

Ofloxacin + Tinidazole works by deploying a synergistic dual antimicrobial mechanism. Ofloxacin blocks bacterial DNA replication by inhibiting DNA gyrase, while tinidazole diffuses into anaerobic cells where it is reduced to intermediate compounds that break DNA strands. It binds to essential nucleic acid structures to prevent protein synthesis and replication. Unlike standard monotherapies, it addresses resistant anaerobic strains and protozoa alongside aerobic bacteria. It is highly effective and well-tolerated for severe abdominal and systemic mixed infections.

Therapeutic Uses

• Amoebic Dysentery: Resolves severe intestinal amoebiasis and mixed bacterial gastrointestinal infections.
• Gynecological Infections: Controls aerobic-anaerobic bacterial vaginosis and pelvic inflammatory conditions.
• Post-Surgical Prophylaxis: Prevents bacterial contamination in abdominal and colorectal surgical procedures.

Why Manufacturers Choose Ofloxacin + Tinidazole

This high-potency combination offers an extended half-life compared to other nitroimidazoles, making it a premium choice for therapeutic compliance. Companies look for Ofloxacin + Tinidazole third party manufacturing in India to access sophisticated formulation expertise that ensures stable multi-layer tablet compression or uniform co-processing. Celesta coordinates production with WHO-GMP compliant units that monitor exact batch specifications using CAS 82419-36-1 active materials. Our partner network leverages WHO-GMP certifications to ensure high quality and standard validation for immediate distribution.